Cambridge, MA · Founded 2019 · Privately Held (backing)
Developer of a molecular diagnostic platform designed to enable point-of-care disease diagnosis. Nanopath is based in Cambridge, MA and was founded in 2019. It was valued at $32 million at its early-stage round in Aug 2022, the last priced event on record. It has raised $16.4 million across 2 recorded rounds; the latest was a $5.3 million debt round in Jan 2025.
PMV mark · valuation
$32.0M
Oct 2026
Priced at
its early-stage round
Aug 2022
Total raised
$16.4M
Last round
Debt
Jan 2025
Cap table — not yet on record
Nanopath's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Nanopath with a free account
·The complete investor list: 17 names
·Watch Nanopath: the Monday email on marks, rounds and moves